ArticleOncoTargets and therapy2014

Combination therapy with brentuximab vedotin and cisplatin/cytarabine in a patient with primarily refractory anaplastic lymphoma kinase positive anaplastic large cell lymphoma.

Simon Heidegger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.